CDTXCidara Therapeutics Inc
CDTX
Cidara Therapeutics Inc8,877
Mkt Cap
$3.37BVolume
654,575.0052W High
$121.2152W Low
$13.90PE Ratio
-8.99CDTX Fundamentals
Price
$150.00Prev Close
$107.12Open
$106.1550D MA
$92.51Beta
0.63Avg. Volume
973,658.52EPS (Annual)
-$26.46P/B
7.36Rev/Employee
$33,552.63
Cidara Therapeutics Shares Surge In After-Hours On Report Of Nearing Merck Deal
(RTTNews) - Merck & Co. Inc. (MRK) is nearing a deal to acquire Cidara Therapeutics (CDTX), a biotechnology company developing a long-acting antibody treatment for influenza, the Financial Times...
Nasdaq News: Markets·1h ago
Cidara Therapeutics (NASDAQ:CDTX) Price Target Raised to $145.00 at Royal Bank Of Canada
Royal Bank Of Canada raised their target price on Cidara Therapeutics from $137.00 to $145.00 and gave the company an "outperform" rating in a research report on Friday...
MarketBeat·5d ago
Cidara Therapeutics (NASDAQ:CDTX) Cut to Sell at Wall Street Zen
Wall Street Zen lowered shares of Cidara Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·6d ago
CDTX Stock Up on FDA's Breakthrough Therapy Tag for CD388 in Influenza
Cidara Therapeutics wins FDA Breakthrough Therapy tag for CD388 for the prevention of seasonal influenza. Stock rises.
Zacks·1mo ago
Cidara Therapeutics Granted FDA Breakthrough Therapy Designation For Flu-Preventing Antiviral
The Breakthrough Therapy designation was awarded to the drug based on the results of a study in which CD388 provided statistically significant prevention of seasonal influenza in healthy unvaccinated adults aged 18-64.
CDTX Stock Soars 218% YTD on Positive Updates From Influenza Program
Cidara Therapeutics' shares surge 218% this year after its flu candidate CD388 hits key mid-stage study goals and advances into pivotal testing.
Zacks·2mo ago
Lithium Americas, Alibaba, uniQure, IREN, Cidara: Stocks Making The Biggest Moves Today
Lithium Americas’ shares skyrocketed over 96% in Wednesday’s afternoon trade after the firm confirmed that it is in talks with the Energy Department and GM over the $2.6 billion Thacker Pass project loan.
Cidara Therapeutics (CDTX) Upgraded to Buy: Here's What You Should Know
Cidara Therapeutics (CDTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·2mo ago
Has Black Diamond Therapeutics (BDTX) Outpaced Other Medical Stocks This Year?
Here is how Black Diamond (BDTX) and Cidara Therapeutics (CDTX) have performed compared to their sector so far this year.
Zacks·2mo ago